Telbivudine is a synthetic nucleoside analogue antiviral agent used in the management of chronic hepatitis B infection. By inhibiting viral DNA polymerase, this medication effectively decreases the replication… Read more

![Chemical structure of (2S,3S,3aR,9aS)-3-Hydroxy-2-(hydroxymethyl)-7-methyl-2,3,3a,9a-tetrahydro-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F433733-92-7-2S3S3aR9aS-3-Hydroxy-2-hydroxymethyl-7-methyl-233a9a-tetrahydro-6H-furo2345oxazolo32-apyrimidin-6-one.png&w=3840&q=75)






Telbivudine is a synthetic nucleoside analogue antiviral agent used in the management of chronic hepatitis B infection. By inhibiting viral DNA polymerase, this medication effectively decreases the replication of the hepatitis B virus, helping to lower viral load in patients. This category provides comprehensive analytical support for the development and assessment of this drug, offering high-quality reference standards of the active pharmaceutical ingredient. Laboratories rely on these materials, including identified process-related impurities, potential degradants, and stable isotope labelled compounds, to perform rigorous impurity profiling and method validation. The inclusion of isotopically labelled internal standards, such as deuterated telbivudine, is essential for accurate quantification during pharmacokinetic studies and routine quality control procedures. These compounds ensure consistency and precision throughout the drug development lifecycle, supporting compliance with regulatory standards for pharmaceutical testing.